Turning pathogens against each other to prevent drug resistance
New research demonstrates that harnessing competition among pathogens inside a patient could extend the life of existing drugs where resistance is already present and prevent resistance to new drugs from emerging.
Eric Barron's talk to trustees he talked specifically about building biomedical sciences and used the Huck as an example
"He noted Huck Institutes of Life Sciences as the model for the collaboration he wants to build. That pours $15 million a year into research and people studying various areas like infectious disease and neural engineering. It brings together seven colleges, 31 departments, 476 educators and 316 graduate students with groundbreaking equipment in 10 different facilities."
Survival of the least-fit: antiviral drug selectively targets nastiest viruses
An antiviral drug that inhibits a virus' replication machinery selectively targets the most aggressive viruses, according to new research that looked at the infection of individual cells by a virus and the consequence of antiviral intervention.